The journey from scientific discovery to a marketable pharmaceutical product is a complex one, heavily reliant on the precise synthesis of chemical compounds. At the heart of this process are pharmaceutical intermediates, the vital building blocks that enable the creation of active pharmaceutical ingredients (APIs). 7-Bromo-1H-quinazolin-4-one, identified by its CAS number 194851-16-6, stands as a significant compound in this domain. NINGBO INNO PHARMCHEM CO.,LTD. is a prominent supplier of this key intermediate, contributing to the efficiency of pharmaceutical synthesis.

The chemical structure of 7-Bromo-1H-quinazolin-4-one is central to its utility. It features a quinazolinone ring system, a bicyclic structure known for its prevalence in biologically active molecules, and a bromine atom at the 7-position. This bromine substituent acts as a versatile functional handle, readily participating in a variety of synthetic transformations. Palladium-catalyzed cross-coupling reactions, such as Suzuki, Stille, and Sonogashira couplings, are frequently employed to modify this position, allowing for the introduction of diverse chemical moieties. This makes 7-bromo-1h-quinazolin-4-one CAS 194851-16-6 an invaluable reagent for constructing intricate molecular frameworks.

The importance of purity in pharmaceutical synthesis cannot be overstated. NINGBO INNO PHARMCHEM CO.,LTD. ensures that its supply of 7-Bromo-1H-quinazolin-4-one meets rigorous quality standards, boasting a minimum purity of 97%. This commitment to high purity is fundamental for ensuring the reliability and reproducibility of chemical reactions, minimizing unwanted byproducts, and ultimately guaranteeing the quality of the final pharmaceutical product. For those seeking dependable pharmaceutical intermediates, this quality assurance is a critical factor.

The applications of 7-Bromo-1H-quinazolin-4-one are widespread within the pharmaceutical industry. It serves as a key precursor in the synthesis of various therapeutic agents, including those with potential anti-cancer, anti-viral, and anti-inflammatory activities. The quinazolinone scaffold itself is a well-established pharmacophore, and the ability to functionalize it at the 7-position through the bromine atom allows medicinal chemists to fine-tune the biological properties of the resulting compounds. The exploration of brominated heterocycles in drug development continues to be a highly productive area of research.

NINGBO INNO PHARMCHEM CO.,LTD. understands the critical needs of the pharmaceutical sector and is dedicated to providing exceptional service alongside its high-quality products. Their expertise in chemical manufacturing and a robust supply chain ensure timely delivery and consistent product availability. By supplying essential building blocks like 7-Bromo-1H-quinazolin-4-one, NINGBO INNO PHARMCHEM CO.,LTD. empowers its clients to accelerate their research and development pipelines and bring life-saving medicines to market more efficiently. Relying on NINGBO INNO PHARMCHEM CO.,LTD. for your organic chemistry intermediates provides a significant competitive advantage.

In essence, 7-Bromo-1H-quinazolin-4-one is a pivotal compound in the complex process of pharmaceutical intermediate synthesis. Its chemical versatility and the assurance of high purity from NINGBO INNO PHARMCHEM CO.,LTD. make it an indispensable tool for advancing medicinal chemistry and pharmaceutical development.